Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis

World Journal of Gastroenterology

Volumn 22, Issue 10, 2016, Pages 3038-3051

  Wang, Zheng ^a   Sheng, Yuan Yuan ^a   Dong, Qiong Zhu ^a   Qin, Lun Xiu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Clinical features; Hepatitis B virus; Hepatitis C virus; Intrahepatic cholangiocarcinoma; Prognosis

Indexed keywords

ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; CA 19-9 ANTIGEN;

ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT CARCINOMA; CANCER PROGNOSIS; DISEASE FREE SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LYMPH NODE METASTASIS; META ANALYSIS; OVERALL SURVIVAL; REVIEW; ADOLESCENT; ADULT; AGED; BILE DUCT NEOPLASMS; CHI SQUARE DISTRIBUTION; CHOLANGIOCARCINOMA; FEMALE; HEPACIVIRUS; HEPATITIS B VIRUS; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; PATHOGENICITY; PROGNOSIS; PROTECTION; RISK FACTOR; TIME FACTOR; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; CHI-SQUARE DISTRIBUTION; CHOLANGIOCARCINOMA; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROTECTIVE FACTORS; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84960539388     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i10.3038     Document Type: Review

References (35)

1. Aljiffry M, Abdulelah A, Walsh M, Peltekian K, Alwayn I, Molinari M. Evidence-based approach to cholangiocarcinoma: A systematic review of the current literature. J Am Coll Surg 2009; 208: 134-147 [PMID: 19228515 DOI: 10.1016/j.jamcollsurg.2008. 09.007]
2. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353-1357 [PMID: 11391522 DOI: 10.1053/jhep.2001.25087]
3. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002; 37: 806-813 [PMID: 12445422 DOI: 10.1016/S0168-8278(02)00297-0]
4. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol 2002; 17: 1049-1055 [PMID: 12201863 DOI: 10.1046/j.1440-1746.2002.02781.x]
5. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366: 1303-1314 [PMID: 16214602 DOI: 10.1016/S0140-6736(05)67530-7]
6. Brown KM, Parmar AD, Geller DA. Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am 2014; 23: 231-246 [PMID: 24560108 DOI: 10.1016/j.soc.2013.10.004]
7. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: A true increase? J Hepatol 2004; 40: 472-477 [PMID: 15123362 DOI: 10.1016/j.jhep.2003.11.030]
8. Zhou Y, Zhao Y, Li B, Huang J, Wu L, Xu D, Yang J, He J. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer 2012; 12: 289 [PMID: 22799744 DOI: 10.1186/1471-2407-12-289]
9. Matsumoto K, Onoyama T, Kawata S, Takeda Y, Harada K, Ikebuchi Y, Ueki M, Miura N, Yashima K, Koda M, Sakamoto T, Endo M, Horie Y, Murawaki Y. Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma. Intern Med 2014; 53: 651-654 [PMID: 24694471 DOI: 10.2169/internalmedicine.53.1410]
10. Zhou H, Wang H, Zhou D, Wang H, Wang Q, Zou S, Tu Q, Wu M, Hu H. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. Eur J Cancer 2010; 46: 1056-1061 [PMID: 20202823 DOI: 10.1016/j.ejca.2010.02.005]
11. Zhou HB, Wang H, Li YQ, Li SX, Wang H, Zhou DX, Tu QQ, Wang Q, Zou SS, Wu MC, Hu HP. Hepatitis B virus infection: A favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. World J Gastroenterol 2011; 17: 1292-1303 [PMID: 21455328 DOI: 10.3748/wjg.v17.i10.1292]
12. Zhang L, Cai JQ, Zhao JJ, Bi XY, Tan XG, Yan T, Li C, Zhao P. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 2010; 101: 233-238 [PMID: 20169539 DOI: 10.1002/jso.21488]
13. Hai S, Kubo S, Yamamoto S, Uenishi T, Tanaka H, Shuto T, Takemura S, Yamazaki O, Hirohashi K. Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 2005; 22: 432-439 [PMID: 16479112 DOI: 10.1159/000091446]
14. Horino K, Beppu T, Komori H, Masuda T, Hayashi H, Okabe H, Takamori H, Baba H. Evaluation of mass-forming intrahepatic cholangiocarcinoma with viral hepatitis. Hepatogastroenterology 2012; 59: 1217-1219 [PMID: 22580675 DOI: 10.5754/hge09739]
15. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg 2010; 8: 336-341 [PMID: 20171303 DOI: 10.1016/j.ijsu.2010.02.007]
16. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses. Eur J Epidemiol 2010; 25: 603-605 [PMID: 20652370 DOI: 10.1007/s10654-010-9491-z]
17. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815-2834 [PMID: 9921604]
18. Farges O, Fuks D, Boleslawski E, Le Treut YP, Castaing D, Laurent A, Ducerf C, Rivoire M, Bachellier P, Chiche L, Nuzzo G, Regimbeau JM. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: A multicenter study by the AFC-IHCC-2009 study group. Ann Surg 2011; 254: 824-829; discussion 830 [PMID: 22042474 DOI: 10.1097/SLA.0b013e318236c21d]
19. Ribero D, Pinna AD, Guglielmi A, Ponti A, Nuzzo G, Giulini SM, Aldrighetti L, Calise F, Gerunda GE, Tomatis M, Amisano M, Berloco P, Torzilli G, Capussotti L. Surgical Approach for Longterm Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients. Arch Surg 2012; 147: 1107-1113 [PMID: 22910846 DOI: 10.1001/archsurg.2012.1962]
20. Lee CH, Chang CJ, Lin YJ, Yeh CN, Chen MF, Hsieh SY. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer 2009; 100: 1765-1770 [PMID: 19436294 DOI: 10.1038/sj.bjc.6605063]
21. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000; 95: 204-207 [PMID: 10638584 DOI: 10.1111/j.1572-0241.2000.01685.x]
22. Miwa S, Miyagawa S, Kobayashi A, Akahane Y, Nakata T, Mihara M, Kusama K, Soeda J, Ogawa S. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 2006; 41: 893-900 [PMID: 17048054 DOI: 10.1007/s00535-006-1877-z]
23. Shen WF, Zhong W, Xu F, Kan T, Geng L, Xie F, Sui CJ, Yang JM. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol 2009; 15: 5976-5982 [PMID: 20014463 DOI: 10.3748/wjg.15.5976]
24. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A populationbased case-control study. Clin Gastroenterol Hepatol 2007; 5: 1221-1228 [PMID: 17689296 DOI: 10.1016/j.cgh.2007.05.020]
25. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115-125 [PMID: 15192785 DOI: 10.1055/s-2004-828889]
26. Li T, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY, Fan J. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection. Liver Int 2014; 34: 953-960 [PMID: 24134199 DOI: 10.1111/liv.12364]
27. Luo X, Yuan L, Wang Y, Ge R, Sun Y, Wei G. Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: A large single-center cohort study. J Gastrointest Surg 2014; 18: 562-572 [PMID: 24395070 DOI: 10.1007/s11605-013-2447-3]
28. Uenishi T, Nagano H, Marubashi S, Hayashi M, Hirokawa F, Kaibori M, Matsui K, Kubo S. The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: A multicenter analysis by Osaka Hepatic Surgery Study Group. J Surg Oncol 2014; 110: 176-181 [PMID: 24760391 DOI: 10.1002/jso.23611]
29. Zhang GW, Lin JH, Qian JP, Zhou J. Identification of risk and prognostic factors for patients with clonorchiasis-associated intrahepatic cholangiocarcinoma. Ann Surg Oncol 2014; 21: 3628-3637 [PMID: 24781504 DOI: 10.1245/s10434-014-3710-x]
30. Liu RQ, Shen SJ, Hu XF, Liu J, Chen LJ, Li XY. Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors. Cancer Cell Int 2013; 13: 99 [PMID: 24139471 DOI: 10.1186/1475-2867-13-99]
31. Wu ZF, Yang N, Li DY, Zhang HB, Yang GS. Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours. J Viral Hepat 2013; 20: 306-310 [PMID: 23565611 DOI: 10.1111/jvh.12005]
32. Jiang BG, Ge RL, Sun LL, Zong M, Wei GT, Zhang YJ. Clinical parameters predicting survival duration after hepatectomy for intrahepatic cholangiocarcinoma. Can J Gastroenterol 2011; 25: 603-608 [PMID: 22059167]
33. Peng NF, Li LQ, Qin X, Guo Y, Peng T, Xiao KY, Chen XG, Yang YF, Su ZX, Chen B, Su M, Qi LN. Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: A possible role of hepatitis B virus. Ann Surg Oncol 2011; 18: 1258-1266 [PMID: 21207172 DOI: 10.1245/s10434-010-1458-5]
34. Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Kinoshita H. Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg 2001; 88: 969-974 [PMID: 11442529 DOI: 10.1046/j.0007-1323.2001.01784.x]
35. Asayama Y, Aishima S, Taguchi K, Sugimachi K, Matsuura S, Masuda K, Tsuneyoshi M. Coexpression of neural cell adhesion molecules and bcl-2 in intrahepatic cholangiocarcinoma originated from viral hepatitis: relationship to atypical reactive bile ductule. Pathol Int 2002; 52: 300-306 [PMID: 12031086 DOI: 10.1046/j.1440-1827.2002.01349.x]